Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BMcV who wrote (2492)	4/21/1999 9:10:00 PM
From: Ed Ajootian	Read Replies (2) of 10280

Bruce, Taxes are not an issue re: my SEPR position since its in a retirement account. Not sure if I'd a done this if taxes applied. The conservative bull spreads I did on SEPR April calls paid off quite handsomely, thank you. Made about 80% profit after transaction costs with little downside risk. SEPR's drug development is taking a lot slower than initially predicted, with the only exception being Claritin II (DCL). Their first wholly owned drug is not as good as they have claimed. Their first licensed drug (Allegra) is stuck on terminal hold. For the blockbuster deals they have signed up, we now have a cloud overhead due to the FTC reviewing them for anti-competitive behavior. I just have a hard time seeing all this and still saying the company's worth > $3.5 billion. I have found a nice boring earnings company to bury my money from the SEPR sells in. I will gladly take my pissy little 15% per year growth from that stock and not have to look at all the gyrations.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next